Rensselaer Polytechnic Institute’s Boleslaw Szymanski, Ph.D., and Chunyu Wang, M.D. Ph.D., have been elected fellows of the American Association for the Advancement Science (AAAS). Steven Cramer, Ph.D., who was elected AAAS Fellow in 2017, was elected Council Member of the Section on Engineering.
TROY, N.Y. — Biopharmaceuticals are necessary, life-saving tools. But the process for making them is time-consuming and costly, particularly when it comes to the process of purification — the removal of unwanted elements like proteins, viruses, and DNA.
Two chemical engineering professors are contributing to the development of a method for rapidly manufacturing biologic drugs.
Bioseparations and bioprocessing expert Steven Cramer, the William Weightman Walker Professor of Polymer Engineering, was elected a fellow of the American Chemical Society (ACS).
Chemical Engineer Honored for Work in Bioseparations and Bioprocessing Steven Cramer William Weightman Walker Professor of Polymer Engineering
The purification of drug components is a large hurdle facing modern drug development. This is particularly true of drugs that utilize proteins, which are notoriously difficult to separate from other potentially deadly impurities.